R R

What Is MOG-Antibody Optic Neuritis?

MOG–antibody optic neuritis is inflammation of the optic nerve associated with antibodies against myelin oligodendrocyte glycoprotein. It can occur in both children and adults and often causes marked optic disc swelling and eye pain with movement. Vision loss can be severe at onset but frequently improves with treatment. MOG–antibody optic neuritis can appear as a single attack or as part of a relapsing demyelinating disease. It is distinct from multiple sclerosis related optic neuritis and from aquaporin–4 neuromyelitis optica.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is MOG-Antibody Optic Neuritis?

MOG–antibody optic neuritis is inflammation of the optic nerve associated with antibodies against myelin oligodendrocyte glycoprotein. It can occur in both children and adults and often causes marked optic disc swelling and eye pain with movement. Vision loss can be severe at onset but frequently improves with treatment. MOG–antibody optic neuritis can appear as a single attack or as part of a relapsing demyelinating disease. It is distinct from multiple sclerosis related optic neuritis and from aquaporin–4 neuromyelitis optica.

read more about mogantibody optic neuritis ...

Copy this HTML:

Copy HTML Copied!

Clinical Features and How It Differs From Typical Optic Neuritis

Patients commonly report subacute vision loss in one or both eyes, color desaturation, and pain when the eyes move. Fundus exam often shows prominent swelling of the optic disc, and bilateral involvement is more frequent than in typical multiple sclerosis related optic neuritis. Children can present with optic neuritis combined with brain or spinal cord symptoms. Recovery after treatment tends to be better than in aquaporin–4 disease, although relapses are common without long term control.

Diagnosis and Testing

Diagnosis relies on a combination of clinical findings, imaging, and antibody testing. Orbital and brain MRI demonstrate optic nerve enlargement and enhancement, sometimes with perioptic sheath involvement. Blood tests look for serum MOG–IgG using cell based assays and also check for aquaporin–4 antibodies. Other causes of optic neuritis, such as infections, sarcoidosis, and multiple sclerosis, are considered and investigated when indicated. Early identification of a MOG–associated pattern helps guide treatment strategy and counseling.

Treatment Approaches

Acute attacks are usually managed with high dose intravenous corticosteroids, followed by an oral taper. Plasma exchange is considered when response to steroids is incomplete or vision loss is profound. For individuals with relapsing disease, long term immunotherapy such as intravenous immunoglobulin or other agents can reduce attack frequency. Treatment choices are individualized based on age, comorbidities, and prior relapse pattern. Regular monitoring of vision and imaging helps assess response.

Prognosis and Follow-Up

Many patients regain good visual acuity after treatment, although subtle deficits in contrast or color vision can persist. Relapses are relatively common, particularly in the early years after the first attack, so close follow up is recommended. Education about early symptoms of recurrence helps people seek prompt care. Long term outcomes depend on relapse control and on involvement of other parts of the central nervous system. Coordination between neurology and ophthalmology supports comprehensive care.

FAQs About MOG-Antibody Optic Neuritis

Is MOG–antibody optic neuritis the same as multiple sclerosis?

No, MOG–associated disease is considered separate from multiple sclerosis and has different imaging patterns, antibody tests, and long term behavior.

Can MOG–antibody optic neuritis affect both eyes at once?

Yes, bilateral attacks are relatively common, especially in children, and can cause dramatic disc swelling in both eyes.

Does vision always return to normal after an attack?

Many people regain reading vision, but some have lingering problems with contrast, color, or visual field even when acuity improves.

Will I need long term treatment after a first attack?

Decisions about maintenance therapy depend on relapse risk, MRI findings, and antibody status. This plan is made with a neurologist and eye specialist.

References

EyeWiki. ?Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis.? https://eyewiki.org/Myelin_Oligodendrocyte_Glycoprotein_%28MOG%29_Optic_Neuritis

Cleveland Clinic. ?MOGAD: What It Is, Diagnosis, Symptoms & Treatment.? https://my.clevelandclinic.org/health/diseases/myelin-oligodendrocyte-glycoprotein-antibody-disease-mogad

Mayo Clinic Laboratories. ?Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).? https://news.mayocliniclabs.com/2023/05/01/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mogad/

Nature Eye. ?MOG antibody-associated optic neuritis.? https://www.nature.com/articles/s41433-024-03108-y

NCBI Bookshelf. ?Optic Neuritis.? https://www.ncbi.nlm.nih.gov/books/NBK557853/